Interest Income Expense - Standard Chem & Pharm Co Ltd (TWSE:1720) - Alpha Spread

Standard Chem & Pharm Co Ltd
TWSE:1720

Watchlist Manager
Standard Chem & Pharm Co Ltd Logo
Standard Chem & Pharm Co Ltd
TWSE:1720
Watchlist
Price: 65.1 TWD 0.46% Market Closed
Market Cap: 11.6B TWD
Have any thoughts about
Standard Chem & Pharm Co Ltd?
Write Note

Standard Chem & Pharm Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Standard Chem & Pharm Co Ltd
Interest Income Expense Peer Comparison

Comparables:
Y
3705
4746
1789
S
4119
1795

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Standard Chem & Pharm Co Ltd
TWSE:1720
Interest Income Expense
NT$130.1m
CAGR 3-Years
N/A
CAGR 5-Years
27%
CAGR 10-Years
26%
Y
YungShin Global Holding Corp
TWSE:3705
Interest Income Expense
NT$284.3m
CAGR 3-Years
265%
CAGR 5-Years
44%
CAGR 10-Years
20%
Formosa Laboratories Inc
TWSE:4746
Interest Income Expense
-NT$826.3m
CAGR 3-Years
N/A
CAGR 5-Years
-63%
CAGR 10-Years
-60%
ScinoPharm Taiwan Ltd
TWSE:1789
Interest Income Expense
NT$53.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
SCI Pharmtech Inc
TWSE:4119
Interest Income Expense
-NT$181k
CAGR 3-Years
84%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Lotus Pharmaceutical Co Ltd
TWSE:1795
Interest Income Expense
NT$506.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Standard Chem & Pharm Co Ltd's Interest Income Expense?
Interest Income Expense
130.1m TWD

Based on the financial report for Jun 30, 2024, Standard Chem & Pharm Co Ltd's Interest Income Expense amounts to 130.1m TWD.

What is Standard Chem & Pharm Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
26%

Over the last year, the Interest Income Expense growth was -22%.

Back to Top